MX2010004555A - Compositions and methods for treating asthma and lung disorders. - Google Patents

Compositions and methods for treating asthma and lung disorders.

Info

Publication number
MX2010004555A
MX2010004555A MX2010004555A MX2010004555A MX2010004555A MX 2010004555 A MX2010004555 A MX 2010004555A MX 2010004555 A MX2010004555 A MX 2010004555A MX 2010004555 A MX2010004555 A MX 2010004555A MX 2010004555 A MX2010004555 A MX 2010004555A
Authority
MX
Mexico
Prior art keywords
compositions
methods
asthma
treating
electrokinetically generated
Prior art date
Application number
MX2010004555A
Other languages
Spanish (es)
Inventor
Anthony B Wood
Richard L Watson
Gregory J Archambeau
Original Assignee
Revalesio Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2007/082580 external-priority patent/WO2008052145A2/en
Priority claimed from PCT/US2007/082578 external-priority patent/WO2008052143A2/en
Priority claimed from PCT/US2007/082581 external-priority patent/WO2008115290A2/en
Application filed by Revalesio Corp filed Critical Revalesio Corp
Priority claimed from PCT/US2008/081386 external-priority patent/WO2009055824A1/en
Publication of MX2010004555A publication Critical patent/MX2010004555A/en

Links

Abstract

Provided are compositions and methods for treating or preventing lung or respiratory disorders or conditions characterized by airflow obstruction or limitation, or a symptom thereof (e.g., asthma, rhinitis, allergic rhinitis (e.g. nose respiratory tract), and chronic obstructive pulmonary disease (COPD) and COPD-associated conditions (e.g., bronchitis, emphysema, asthma), emphysema, pneumonia, bronchitis, influenza, SARS, tuberculosis, and whooping cough (pertussis), and the like) in a subject in need thereof by administering a therapeutic composition comprising at least one electrokinetically generated fluid (including gas-enriched electrokinetically generated fluids) as disclosed herein, the electrokinetically altered aqueous fluid suitable to alter cellular membrane structure or function sufficient to provide for modulation of intracellular signal transduction, wherein treating a lung disorder or a symptom thereof is thereby afforded. Additional aspects relate to therapeutic compositions, and combination treatment methods comprising administration of at least one electrokinetically generated fluid in combination with at least one additional therapeutic agent.
MX2010004555A 2007-04-28 2008-10-27 Compositions and methods for treating asthma and lung disorders. MX2010004555A (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US4841607P 2007-04-28 2007-04-28
US98272007P 2007-10-25 2007-10-25
US98271907P 2007-10-25 2007-10-25
PCT/US2007/082580 WO2008052145A2 (en) 2006-10-25 2007-10-25 Methods of therapeutic treatment of eyes and other human tissues using an oxygen-enriched solution
PCT/US2007/082578 WO2008052143A2 (en) 2006-10-25 2007-10-25 Mixing device and output fluids of same
PCT/US2007/082581 WO2008115290A2 (en) 2006-10-25 2007-10-25 Methods of wound care and treatment
US4833208P 2008-04-28 2008-04-28
US4840408P 2008-04-28 2008-04-28
US4834708P 2008-04-28 2008-04-28
US4834008P 2008-04-28 2008-04-28
PCT/US2008/081386 WO2009055824A1 (en) 2007-10-25 2008-10-27 Compositions and methods for treating asthma and lung disorders

Publications (1)

Publication Number Publication Date
MX2010004555A true MX2010004555A (en) 2010-07-28

Family

ID=42830643

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010004555A MX2010004555A (en) 2007-04-28 2008-10-27 Compositions and methods for treating asthma and lung disorders.

Country Status (1)

Country Link
MX (1) MX2010004555A (en)

Similar Documents

Publication Publication Date Title
NO20075287L (en) Combination of anticholinergics and leukotnene receptor antagonists for the treatment of respiratory disorders
NO20072920L (en) Combination of Methylxanthine Compounds and Steroids to Treat Chronic Respiratory Diseases
CY1108326T1 (en) A NEW COMBINATION OF ANTI-CLINICAL AND BREATHING FOR MENTAL RESPIRATORY DISEASES
AU2006329199A8 (en) Treatment of respiratory diseases
ME00077B (en) Formoterol superfine formulation
WO2012047674A3 (en) Methods and compositions for disease treatment using inhalation
WO2007109118A3 (en) RECOMBINANT HUMAN CC 10 (rhCC10) FOR TREATMENT OF RESPIRATORY DISORDERS
GEP20227366B (en) Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disorders
BRPI0806392A8 (en) use of aclidinium, aclidinium, treatment or prevention method and pharmaceutical composition
NO20083683L (en) Nebulisatorformulering
WO2006083322A3 (en) Methods for the treatment and prevention of infection using anti-selectin agents
NO20073909L (en) Nebulized formulation
MX2009013926A (en) Ethynylindole compounds.
MX2010004555A (en) Compositions and methods for treating asthma and lung disorders.
WO2004113286A3 (en) Mucin synthesis inhibitors
EA201201393A1 (en) INHALER, DEVELOPED FOR DELIVERY OF MEDICINES AS DRY POWDER
EA201201389A1 (en) INHALER, CREATING TURBULENCE
NO20081483L (en) Combination of compounds that can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (COPD) and asthma
MX2010008685A (en) Dual pharmacophores-pde4-muscarinic antagonistics.
MX2020010977A (en) Methods of treating fungal infections.
EP1661892A4 (en) Condensed ring compound and use thereof
WO2007046113A3 (en) Novel pharmaceutical composition comprising alkaloid and process thereof
Allam et al. Effect of combination of Acapella device and breathing exercises on treatment of pulmonary complications after upper abdominal surgeries
Velasco et al. Aerosol delivery in a pediatric model of non-invasive ventilation
WO2007066151A3 (en) Topical compositions for treatment of respiratory disorders

Legal Events

Date Code Title Description
FG Grant or registration